Announce Date | 08/01/2025 |
EPS Normalized Actual | $0.22 (Beat by $0.0329) |
EPS GAAP Actual | $0.22 (Beat by $0.0329) |
Revenue Actual | $3.1477B |
Revenue Surprise | Beat by $3147.7M |
Announce Date | 09/30/2025 (Pre-Market) |
EPS Normalized Estimate | $0.21592 |
EPS GAAP Estimate | $0.21592 |
Revenue Estimate | $3.155707211B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 2 | 41.51 | 2 | 2 | 1 |
Dec 2028 | 1.71 | 48.55 | 1.71 | 1.71 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (Jun 2025) | 0.05 | -0.13282 | 3.1477B | 100% | 167.58M |
FQ1 2025 (Mar 2025) | 0.05 | -0.040972 | 2.87813B | 100% | 165.7M |
FQ4 2024 (Dec 2024) | 0.0799 | 0.0799 | 3.0528B | 100% | 3052.8M |
FQ3 2024 (Sep 2024) | -0.0415 | -0.0415 | 2.90682B | 22.37% | 2906.82M |
FQ1 2021 (Mar 2021) | 0 | 0 | 1.51445B | 100% | 1514.45M |
FQ2 2021 (Jun 2021) | 0 | 0 | 1.64598B | 100% | 1645.98M |
FQ3 2021 (Sep 2021) | 0 | 0 | 1.73616B | 100% | 1736.16M |
FQ3 2022 (Sep 2022) | -0.13 | -0.13 | 1.98142B | 12.38% | 1981.42M |
FQ4 Announce Date
09/30/2025 (Pre-Market)
Consensus EPS Estimates
0.21592
Consensus Revenue Estimates
3.155707211B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 0.43186 | -- | 0.43186 | 0.43186 | 1 |
FQ3 2027 (Sep 2027) | 0.25212 | -- | 0.25212 | 0.25212 | 1 |
FQ2 2027 (Jun 2027) | 0.21393 | -- | 0.21393 | 0.21393 | 1 |
FQ1 2027 (Mar 2027) | 0.32231 | -- | 0.32231 | 0.32231 | 1 |
FQ4 2026 (Dec 2026) | 0.36752 | -- | 0.36752 | 0.36752 | 1 |
FQ3 2026 (Sep 2026) | 0.2278 | -- | 0.2278 | 0.2278 | 1 |
FQ2 2026 (Jun 2026) | 0.21522 | 76.77 | 0.21522 | 0.21522 | 1 |
FQ1 2026 (Mar 2026) | 0.24827 | 79.86 | 0.24827 | 0.24827 | 1 |
FQ4 2025 (Dec 2025) | 0.30238 | 73.58 | 0.30238 | 0.30238 | 1 |
FQ3 2025 (Sep 2025) | 0.21592 | 119.22 | 0.21592 | 0.21592 | 1 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 4.29B | -- | 4.29B | 4.29B | 1 |
FQ3 2027 (Sep 2027) | 3.95B | -- | 3.95B | 3.95B | 1 |
FQ2 2027 (Jun 2027) | 3.74B | -- | 3.74B | 3.74B | 1 |
FQ1 2027 (Mar 2027) | 3.67B | -- | 3.67B | 3.67B | 1 |
FQ4 2026 (Dec 2026) | 3.79B | -- | 3.79B | 3.79B | 1 |
FQ3 2026 (Sep 2026) | 3.57B | -- | 3.57B | 3.57B | 1 |
FQ2 2026 (Jun 2026) | 3.38B | 7 | 3.38B | 3.38B | 1 |
FQ1 2026 (Mar 2026) | 3.24B | 11.24 | 3.24B | 3.24B | 1 |
FQ4 2025 (Dec 2025) | 3.33B | 8.22 | 3.33B | 3.33B | 1 |
FQ3 2025 (Sep 2025) | 3.16B | 7.89 | 3.16B | 3.16B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
1
EPS # of Misses
4
EPS # of in-lines
3
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | 0.18282 | 0.05 | -0.13282 | -265.64% |
FQ1 2025 (Mar 2025) | 0.090972 | 0.05 | -0.040972 | -81.94% |
FQ4 2024 (Dec 2024) | 0.0799 | 0.0799 | 100% | |
FQ3 2024 (Sep 2024) | -0.0415 | -0.0415 | 100% | |
FQ1 2021 (Mar 2021) | 0 | 0 | NAN% | |
FQ2 2021 (Jun 2021) | 0 | 0 | NAN% | |
FQ3 2021 (Sep 2021) | 0 | 0 | NAN% | |
FQ3 2022 (Sep 2022) | -0.13 | -0.13 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | $2.98B | $3.15B | $167.58M | 5.32% |
FQ1 2025 (Mar 2025) | $2.71B | $2.88B | $165.7M | 5.76% |
FQ4 2024 (Dec 2024) | $0B | $3.05B | $3052.8M | 100% |
FQ3 2024 (Sep 2024) | $0B | $2.91B | $2906.82M | 100% |
FQ1 2021 (Mar 2021) | $0B | $1.51B | $1514.45M | 100% |
FQ2 2021 (Jun 2021) | $0B | $1.65B | $1645.98M | 100% |
FQ3 2021 (Sep 2021) | $0B | $1.74B | $1736.16M | 100% |
FQ3 2022 (Sep 2022) | $0B | $1.98B | $1981.42M | 100% |